Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 33.66
+9.86 (41.43%)
Aug 20, 2026, 4:09 PM HKT
Everest Medicines Employees
Everest Medicines had 812 employees as of December 31, 2025. The number of employees increased by 147 or 22.11% compared to the previous year.
Employees
812
Change (1Y)
147
Growth (1Y)
22.11%
Revenue / Employee
3.42M HKD
Profits / Employee
-76.66K HKD
Market Cap
11.83B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 812 | 147 | 22.11% |
| Dec 31, 2024 | 665 | 233 | 53.94% |
| Dec 31, 2023 | 432 | 67 | 18.36% |
| Dec 31, 2022 | 365 | -40 | -9.88% |
| Dec 31, 2021 | 405 | 256 | 171.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,110 |
| Lepu Biopharma | 710 |
| Alphamab Oncology | 498 |
| Suzhou Ribo Life Science | 407 |
| CARsgen Therapeutics Holdings | 355 |
| Abbisko Cayman | 276 |
| Ascletis Pharma | 202 |
| CStone Pharmaceuticals | 136 |
Everest Medicines News
- 1 day ago - Everest Medicines Earnings Call Transcript: H1 2026 - Transcripts
- 1 day ago - Everest Medicines Earnings release: H1 2026 - Filings
- 2 months ago - LENZ Therapeutics Secures $85 Million Potential from Everest Medicines Deal - GuruFocus
- 2 months ago - Everest Medicines Acquires Rights To Develop And Commercialize VIZZ In Greater China - Nasdaq
- 2 months ago - LENZ Announces Everest Medicines' Acquisition of VIZZ Rights in Greater China - GuruFocus
- 2 months ago - Travere Therapeutics Partners with Everest Medicines for $1.14 Billion Kidney Drug Deal - GuruFocus
- 4 months ago - Everest Medicines Slides: Acquisition presentation - Filings
- 4 months ago - China biotech flow picks up as Everest seals US$250 million deal - South China Morning Post